Minerva Surgical, INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$568Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
6,198clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $219K
2020 $29K
2021 $34K
2022 $79K
2023 $93K
2024 $54K
2025 $61K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Obstetrics & Gynecology $488K
Gynecology $25K
Obstetrics $9,477
Reproductive Endocrinology $3,358
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $3,320
Family $2,653

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Soheil Amin Hanjani Brockton, MA Obstetrics & Gynecology $59,325.27
David Glassman Phoenix, AZ Obstetrics & Gynecology $34,061.47
John Sunyecz Hopwood, PA Obstetrics & Gynecology $13,703.13
Robert Asgharian El Paso, TX Obstetrics & Gynecology $8,689.87
Amanpreet Bhullar Orlando, FL Obstetrics & Gynecology $7,698.66
Rebecca Russell Wooster, OH Obstetrics & Gynecology $6,602.87
Amy Garcia Albuquerque, NM Gynecology $6,592.85
James Brown North Syracuse, NY Obstetrics & Gynecology $5,196.81
Michael Fitzpatrick Round Rock, TX Obstetrics & Gynecology $5,076.31
Steven Richman Mount Laurel, NJ Obstetrics & Gynecology $4,719.04

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.